Meet our sponsors...
Limited sponsorship and exhibition opportunities still remain - please contact Sylvester Gabriel for more information.
Gold:
BD Biosciences is one of three business segments of BD (Becton, Dickinson and Company) built on BD's 100-year foundation of quality, reliability, and commitment to customers and business partners around the world. As one of the largest businesses supporting the life sciences today, BD Biosciences offers expertise in cellular biology, immunology, and cell analysis.
BD Biosciences provides integrated, high-value products and services for genomics, proteomics, drug discovery & development, oncology, and immune function. Our customers include academic and government institutions focused on basic and clinical research in the life sciences; biotechnology and pharmaceutical companies engaged in drug discovery and development; and hospitals, reference laboratories, and blood banks that perform patient testing and monitoring for quality control.
» Visit BD
Finesse Solutions – Leading the way in developing new measurement and control technologies in order to enable the transition to single-use systems, bring new capabilities to existing bioreactor platforms, and harmonize global bio-process information transfer. Our current product family provides comprehensive measurement and control solutions for upstream processes in the biotech and pharmaceutical industries.
» Visit Finesse Solutions
Lonza is one of the world's leading suppliers to the pharmaceutical, healthcare and life science industries. Its products and services span its customers’ needs from research to final product manufacture. Lonza is the global leader in the production and support of active pharmaceutical ingredients both chemically as well as biotechnologically. Biopharmaceuticals are one of the key growth drivers of the pharmaceutical and biotechnology industries. Lonza has strong capabilities in large and small molecules, peptides, amino acids and niche bioproducts which play an important role in the development of novel medicines and healthcare products. Lonza is a leader in cell culture media and reagents for biopharmaceutical manufacturing, cell-based research, endotoxin detection and cell therapy manufacturing. Since February 08, Lonza is as well the exclusive distributor of the CELL-tainer™ from CELLution Biotech. Lonza is also a leading provider of value chemical and biotech ingredients to the nutrition, hygiene, preservation, agro and personal care markets.
» Visit Lonza
Cyntellect is a cell purification and analysis company dedicated to unleashing the power of living cells for applications in life sciences, diagnostics, drug discovery and regenerative medicine. Live cells have become the cornerstone of drug discovery and are projected to be critically important in future diagnostic and therapeutic applications. The efficient analysis and purification of live cells in a precise, reproducible and sterile manner will be paramount to enabling this revolution. Cyntellect’s automated laser-based cell processing technology (LEAP TM) can analyze and purify live cells with great precision and efficiency within a closed in situ system environment that is truly enabling for life science research, pharmaceutical drug discovery, biopharmaceutical cell line development, diagnostic rare cell analysis and stem cell purification.
The Company has launched products and services and established scientific and business collaborations with leading academic centers of excellence and commercial institutions in the life sciences, biopharmaceutical and drug discovery segments. Cyntellect has conducted such relationships in a variety of areas relating to cell line development, cell sample preparation, stem cell purification, small molecule drug discovery and functional genomics, with potential for many new and exciting applications including rare cell detection for diagnostics.
visit Cyntellect
Cocktail sponsor:
From early research to realising the promise of stem cell breakthroughs, our extensive line of instruments, equipment, consumables, reagents and software enable the entire workforce. Thermo Scientific offer a wide range of products to advance your workflow which includes collection, purification, expansion, differentiation, characteristics, analysis, storage and transport. Visit: www.thermo.com/stemcell
Associate:
iZumi Bio, Inc. was founded in 2007 and is funded by Kleiner Perkins Caufield and Byers and Highland Capital Partners. iZumi is using the power of induced pluripotent stem cells (iPS) to transform drug discovery and regenerative medicine. The name iZumi, which means "fountain of youth", was chosen to honor the Japanese origins of iPS technology. iZumi is located in Mountain View, California.
» Visit iZumi Bio
Invitrogen Corporation (NASDAQ: IVGN) provides products and services that support academic and government research institutions and pharmaceutical and biotech companies worldwide in their efforts to improve the human condition. The company provides essential life science technologies for disease research, drug discovery, and commercial bioproduction. Invitrogen’s own research and development efforts are focused on breakthrough innovation in all major areas of biological discovery including functional genomics, proteomics, stem cells, cell therapy and cell biology – placing Invitrogen’s products in nearly every major laboratory in the world. Founded in 1987, Invitrogen is headquartered in Carlsbad, CA, and conducts business in more than 70 countries around the world. The company employs approximately 4,700 scientists and other professionals and had revenues of approximately $1.3 billion in 2007.
» Visit Invitrogen
Gamida Cell Ltd. is a world leader in stem cell expansion technologies and therapeutic products. The company is developing a pipeline of cell therapeutics to effectively treat debilitating and often fatal illnesses such as cancer, cardiac disease and peripheral vascular disease (PVD). Gamida Cell’s therapeutic candidates contain adult stem cells, selected from non-controversial sources, such as umbilical cord blood. These stem cells are then enriched in culture using the company’s proprietary technologies. Gamida Cell’s flagship product, StemEx, is currently being studied as a treatment for hematological malignancies in a global, multi-center, FDA/European regulatory guided, pivotal registration study called ExCell ( www.stemexstudy.com). Gamida collaborations include a joint venture with Teva Pharmaceuticals and a licensing agreement with Amgen. The company is also planning to initiate a series of Phase I/II clinical studies which will include cardiac tissue regeneration in patients post myocardial infarction, and another in patients with Peripheral Vascular Disease.
Institute of Cell Therapy is a scientific and research, medical and diagnostic institution. The Institute is engaged in the development and introduction into medical practice the most recent scientific advances in the fields of cellular technology, cryomedicine and non-medicamental treatment. The Institute is a holder of 28 patents and certificates in the field of use of stem cells.
The Institute of Cell Therapy included (clinical, research units, cryobanks stem cells). Today, the Institute of Cell therapy is the basis for clinical trials on the use of stem cells in treating a number of serious diseases. For more information on the Institute's activities, please visit www.stemcellclinic.com
Cellerix is a product-focused biopharmaceutical company developing innovative medicines based on cell therapy. The Company is a recognised leader in the research and application of expanded autologous (patient-derived) and allogeneic (donor-derived) cells of adult origin in severe diseases with high unmet medical need.
The Company has a clinical stage product pipeline in the area of tissue repair and owns two of the first three cell therapy products with Orphan Drug status in Europe.
Cellerix is also developing a new generation of products based on expanded allogeneic stem cells that are derived from various donors (Cx601 and Cx611 programmes). The first of these programmes will enter phase II clinical trials in 2009. Visit: www.cellerix.com
For more than 20 years PAA Laboratories has specialized in the production of high quality cell culture products including media, sera, reagents and buffer solutions.
Intensive collaboration with the Austrian Ministry of Health and our investment in facilities and capabilities has enabled PAA to develop a new product standard for raw material used in the manufacture of Advanced Therapy Medicinal Products (ATMP). PAA was granted a GMP licence for the production of “in vivo products for tissue cultures”, warranting maximum safety and consistency. Thus, the product line ATMP-Ready meets the requirements laid down in the regulation EC/1934/2007.
Recently we expanded our GMP compliant manufacturing site in Europe with a new powder media production unit. Together with state-of-the-art production facilities in North America and Australia, seven sales subsidiaries and more than 50 distributors PAA provides the highest level of customer service. Visit: http://www.paa.com/
EUFETS AG, a company of the global Fresenius Group, is a GMP certified Contract Manufacturing Organisation (CMO) dedicated since more than 10 years to the GMP manufacturing of cell and gene therapy products.
EUFETS offers process development services, pre-GMP and cGMP manufacturing to support biotechnology companies and academic institutions worldwide.
Our services include the supply of materials for early stage drug development and phase I to III clinical trials such as MCB/WCB cell banks, autologous/allogeneic cell products (e.g. stem cells or T-cells) and other human cells/cell lines, viral vectors and gene modified cells/cell lines.
EUFETS runs a 500 m2 state-of-the-art GMP production facility (BSL 2 & 3**) and has more than 600 m2 of laboratory space.
EUFETS also supports preclinical product development (R&D/GLP studies) of biologics with customized in vitro bioanalytical programs.
For more information, please visit www.eufets.com
Meso Scale Discovery (MSD®) develops and markets solutions for singleplex and multiplex biological assays, including assays for toxicology biomarkers, metabolic biomarkers, cytokines, and phosphoproteins. MSD's platform is based on MULTI-ARRAY® technology, a proprietary combination of patterned arrays and electrochemiluminescence detection, enabling large numbers of measurements with exceptional sensitivity, wide dynamic range, and convenience.
 Millipore is a Life Science leader providing cutting-edge technologies, tools, and services for bioscience research and biopharmaceutical manufacturing. As a strategic partner, we collaborate with customers to confront the world's challenging human health issues. From research to development to production, our scientific expertise and innovative solutions help customers tackle their most complex problems and achieve their goals.
Visit our website: www.millipore.com
|
